During the past decade, Thumbay Hospital New life / Endocrinology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Thumbay Hospital New life / Endocrinology" are "Diabetes Mellitus" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Thumbay Hospital New life / Endocrinology" in a lesser frequency.

Most popular intervention types in "Thumbay Hospital New life / Endocrinology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Canagliflozin + Metformin hydrochloride (Fixed Dose Combination)" (1 trials), "Canagliflozin 100 mg" (1 trials), "Canagliflozin 300 mg" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Thumbay Hospital New life / Endocrinology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Thumbay Hospital New life / Endocrinology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Thumbay Hospital New life / Endocrinology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Thumbay Hospital New life / Endocrinology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".